nitrofurantoin and tirzepatide Injection HomeKit Risks of Long-Term Nitrofurantoin Use

While data is still being collected and reviewed, the SELECT trial demonstrated a 20% relative reduction in major adverse cardiovascular events in patients treated with semaglutide

Compounded medications are not FDA approved, and the FDA does not review them for safety, effectiveness, or quality before marketing

Were very excited to release our October weight loss data from our weight management program that includes semaglutide (the active ingredient found in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro)

Our new modernized R&D and manufacturing will be completed in 2025

Semaglutide primarily targets GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors